Literature DB >> 8910289

6'-Sulfo sialyl Lex but not 6-sulfo sialyl Lex expressed on the cell surface supports L-selectin-mediated adhesion.

S Tsuboi1, Y Isogai, N Hada, J K King, O Hindsgaul, M Fukuda.   

Abstract

In order to determine if a sulfated oligosaccharide on the cell surface can function as an L-selectin ligand, a novel approach for in vitro transfer of oligosaccharides was utilized (Srivastava, G., Kaun, K. J., Hindsgaul, O., and Palcic, M. M. (1992) J. Biol. Chem. 267, 22356-22361). CHO cells were incubated with synthetic 6'-sulfo sialyl Lex, NeuNAcalpha2-->3(sulfate-6)Galbeta1-->4(Fucalpha1-->3) GlcNAc or 6-sulfo sialyl Lex, NeuNAcalpha2-->3Galbeta1-->4[(Fucalpha1-->3)sulfate--> 6GlcNAc] oligosaccharide linked to C-6 of a fucose residue in GDP-fucose and a milk fucosyltransferase. The resultant CHO cells expressing 6'-sulfo sialyl Lex or 6-sulfo sialyl Lex on their cell surface were tested for adhesion to E-selectin and L-selectin chimeric proteins coated on plates. The results indicate that 6'-sulfo sialyl Lex supports L-selectin-mediated adhesion much better than sialyl Lex similarly tagged on the cell surface. In contrast, 6-sulfo sialyl Lex containing a sulfate group on the N-acetylglucosamine residue did not support adhesion with either selectin. These combined results suggest that 6'-sulfo sialyl Lex is a much better ligand than sialyl Lex oligosaccharide for L-selectin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910289     DOI: 10.1074/jbc.271.44.27213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection.

Authors:  S D Rosen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Characterization of a spleen sulphotransferase responsible for the 6-O-sulphation of the galactose residue in sialyl-N-acetyl-lactosamine sequences.

Authors:  R G Spiro; V D Bhoyroo
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 3.  Selectin ligands: will the real ones please stand up?

Authors:  A Varki
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Sulfated sialic acid-polymers inhibit the cytotoxic action of bee and snake venom.

Authors:  Y Oda; M Kinoshita; K Hamada; K Nakayama; Y Ohta; S Yamaguchi; Y Tsukada; Y Kawai; K Kakehi
Journal:  Glycoconj J       Date:  1999-08       Impact factor: 2.916

5.  Reconstitution of functional L-selectin ligands on a cultured human endothelial cell line by cotransfection of alpha1-->3 fucosyltransferase VII and newly cloned GlcNAcbeta:6-sulfotransferase cDNA.

Authors:  N Kimura; C Mitsuoka; A Kanamori; N Hiraiwa; K Uchimura; T Muramatsu; T Tamatani; G S Kansas; R Kannagi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 6.  A journey to the world of glycobiology.

Authors:  A Kobata
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

7.  Characterization of distinct Gal:3-O-sulfotransferase activities in human tumor epithelial cell lines and of calf lymph node GlcNAc : 6-O-sulfotransferase activity.

Authors:  E V Chandrasekaran; R K Jain; J M Rhodes; R Chawda; C Piskorz; K L Matta
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

8.  Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses.

Authors:  S Tsuboi; M Fukuda
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

9.  Sialyltransferase ST3Gal-III regulates Siglec-F ligand formation and eosinophilic lung inflammation in mice.

Authors:  Maho Suzukawa; Marina Miller; Peter Rosenthal; Jae Youn Cho; Taylor A Doherty; Ajit Varki; David Broide
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

10.  CMP substitutions preferentially inhibit polysialic acid synthesis.

Authors:  Tatsuo Miyazaki; Kiyohiko Angata; Peter H Seeberger; Ole Hindsgaul; Minoru Fukuda
Journal:  Glycobiology       Date:  2007-12-12       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.